AASLD guidelines classification scheme: Difference between revisions

Jump to navigation Jump to search
Line 23: Line 23:
==Adapted Classification==
==Adapted Classification==
AASLD has adapted the recommendations classification from American Heart Association recommendations classification. The adapated classification is as follows:
AASLD has adapted the recommendations classification from American Heart Association recommendations classification. The adapated classification is as follows:
{|class="wikitable"
! Classification !! Description
|-
| Class I  ||
|-
| CLass II ||
|-
| Class IIa ||
|-
| Class IIb ||
|-
| Class III ||
|}


==References==
==References==

Revision as of 05:26, 27 October 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

AASLD (American Association of Study of Liver Disease) provides recommendations for various liver diseases. It develops clinical practice guidelines which are supported by a high level of scientific evidence. They assist in appropriate health care to patients. The clinical practice guidelines should not be looked at as "standards of care". They are provided to aid in the diagnosis and management of liver diseases.[1]

Classification of Recommendations

AASLD recommendations are classified into five grades based on quality of evidence.[2]

Grade Definition
Grade I Randomized controlled trials
Grade II - 1 Controlled trials without randomization
Grade II - 2 Cohort or case-control analytic studies
Grade II - 3 Multiple time series, dramatic uncontrolled experiments
Grade III Opinions of respected authorities, descriptive epidemiology

Adapted Classification

AASLD has adapted the recommendations classification from American Heart Association recommendations classification. The adapated classification is as follows:

Classification Description
Class I
CLass II
Class IIa
Class IIb
Class III

References

  1. "American Association for the Study of Liver Diseases: Welcome to AASLD". Retrieved 2012-10-25.
  2. Woolf SH, Sox HC (1991). "The Expert Panel on Preventive Services: continuing the work of the U.S. Preventive Services Task Force". American Journal of Preventive Medicine. 7 (5): 326–30. PMID 1790039. |access-date= requires |url= (help)

Template:WH Template:WS